GlycoMimetics(GLYC) - 2023 Q4 - Earnings Call Transcript

GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Conference Call March 27, 2024 8:30 AM ET Company Participants Christian Dinneen-Long - General Counsel Harout Semerjian - CEO Edwin Rock - Chief Medical Officer Bruce Johnson - Chief Commercial Officer Brian Hahn - CFO Conference Call Participants Tara Bancroft - TD Cowen Naureen Quibria - Capital One Securities Edward White - H.C. Wainwright Operator Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this tim ...